Nguyen Alexander T, Chang Edward I, Suami Hiroo, Chang David W
Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,
Ann Surg Oncol. 2015 Sep;22(9):2919-24. doi: 10.1245/s10434-015-4408-4. Epub 2015 Jan 27.
Lymphedema is a common, progressive, and often debilitating condition that can occur after breast cancer treatment. Preliminary reports on vascularized lymph node transfer (VLNT) have been promising. We propose an algorithmic approach to simultaneous VLNT with microvascular breast reconstruction (MBR) and provide early results.
All patients who underwent simultaneous VLNT with MBR were included. Postoperative evaluation was performed at standardized time points and included qualitative assessment and quantitative volumetric analysis.
Between 2011 and 2013, 29 consecutive patients with refractory lymphedema secondary to breast cancer treatment underwent simultaneous VLNT with MBR. Mean follow-up was 11 months. On average, patients had experienced 3.3 years of lymphedema symptoms with 21 % increased volume in the affected arm compared with the unaffected arm. Using our algorithmic approach, all patients underwent successful breast reconstruction. There were no flap losses, and no patients developed donor site lymphedema. Six patients (21 %) experienced donor site wound complications that resolved with conservative measures; 23 patients (79 %) reported sustained symptomatic improvement after reconstruction. The mean volume differential volumes improved to 20, 19, 14, and 10 % at 1, 3, 6, and 12 months after reconstruction, respectively.
Our algorithm provides a reliable approach to optimizing simultaneous abdominal free flap breast reconstruction and VLNT and demonstrates promising results. Long-term studies are warranted to further delineate and improve the safety and efficacy of lymph node transfers.
淋巴水肿是一种常见的、进行性的且往往使人衰弱的病症,可发生于乳腺癌治疗后。关于带血管淋巴结转移(VLNT)的初步报告很有前景。我们提出一种算法方法,用于在进行微血管乳房重建(MBR)的同时进行VLNT,并给出早期结果。
纳入所有同时进行VLNT和MBR的患者。在标准化时间点进行术后评估,包括定性评估和定量容积分析。
2011年至2013年期间,29例因乳腺癌治疗继发难治性淋巴水肿的患者同时接受了VLNT和MBR。平均随访时间为11个月。患者平均经历了3.3年的淋巴水肿症状,患侧手臂体积比未患侧增加了21%。使用我们的算法方法,所有患者均成功进行了乳房重建。没有皮瓣丢失,也没有患者发生供区淋巴水肿。6例患者(21%)出现供区伤口并发症,经保守治疗后痊愈;23例患者(79%)报告重建后症状持续改善。重建后1、3、6和12个月时,平均体积差异分别改善至20%、19%、14%和10%。
我们的算法为优化同期腹壁游离皮瓣乳房重建和VLNT提供了一种可靠的方法,并显示出有前景的结果。需要进行长期研究以进一步明确和提高淋巴结转移的安全性和有效性。